Advances in Dermatology and Allergology
eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current Issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
6/2025
vol. 42
 
Share:
Share:
abstract:
Original paper

Development and validation of a predictive risk nomogram for atopic dermatitis

Jiayue Cui
1
,
Yahui Song
1
,
Qin Rui
1

  1. The Fourth Affiliated Hospital of Soochow University, Suzhou Dushu Lake Hospital, Medical Centre of Soochow University/Centre of Clinical Laboratory and Translational Medicine, Suzhou, China
Adv Dermatol Allergol 2025; XLII (6): 585–593
Online publish date: 2026/01/12
View full text Get citation
 
Introduction
Atopic dermatitis (AD) is the non-fatal skin disease with the highest global disease burden.

Aim
This study investigates the factors influencing AD incidence and aims to construct a predictive risk nomogram model.

Material and methods
A total of 469 patients with dermatitis and eczema who were treated at the Dermatology Department of the Fourth Affiliated Hospital of Soochow University from January 2021 to May 2025 were included, and categorized into an AD group (n = 216) and a non-AD group (n = 253). Differences between the two groups were analysed through univariate analyses, followed by multivariate logistic regression. A predictive model was then constructed. The diagnostic performance of the model was evaluated using calibration curve, Hosmer-Lemeshow (H-L) test, receiver operating characteristic (ROC) curve, and clinical decision curve analysis (DCA) approaches.

Results
Significant differences were observed between the AD and non-AD groups in terms of age, history of allergic diseases, family history of allergy, infantile onset history, number of medical visits, blood eosinophil count, and serum total immunoglobulin E levels (p < 0.001). Logistic regression analysis showed that the number of medical visits (OR = 1.16, 95% CI: 1.08–1.24), history of allergic diseases (OR = 2.68, 95% CI: 1.44–5.00), family history of allergy (OR = 2.30, 95% CI: 1.27–4.17), and infantile onset history (OR = 23.80, 95% CI: 2.92–193.62) were significant factors influencing AD incidence. Calibration curve, H-L test (2 = 6.68, p = 0.57 in the training set and 2 = 7.96, p = 0.44 in the validation set) and area under the ROC curve tests (0.808 in the training set and 0.812 in the validation set) demonstrated that the model exhibited good fit and predictive accuracy. The DCA results indicated that the model provided certain net clinical benefits in predicting AD.

Conclusions
Factors including frequent hospital visits, history of allergic diseases, family history of allergy, and infantile onset are closely associated with the occurrence of AD. The model based on these risk factors developed herein offers significant value as a potential tool for predicting the occurrence of AD.

keywords:

atopic dermatitis, nomogram, risk prediction, IgE, eosinophils

Quick links
© 2026 Termedia Sp. z o.o.
Developed by Bentus.